Robin Kramer

Chief Financial Officer · Biogen

Biotechnology

Robin Kramer is Biogen’s chief financial officer, following accounting leadership at Biogen, Hertz and Fisher Scientific and partner roles in public accounting.

Last reviewed: Nov 2, 2026

Robin Kramer

Chief Financial Officer
Biogen

Last Reviewed: November 2, 2026

Executive Summary

Robin Kramer is Biogen’s chief financial officer, following accounting leadership at Biogen, Hertz and Fisher Scientific and partner roles in public accounting.

Career Highlights

  • Became Biogen CFO in March 2025.
  • Joined Biogen as vice president and chief accounting officer in November 2018.
  • Previously served as Hertz’s senior vice president and chief accounting officer from 2014 to 2018.

Professional Journey

Kramer’s public accounting career included partner positions at Arthur Andersen and Ernst & Young. From 2004 to 2005, she was director of external reporting, accounting and control at Gillette, followed by service as chief accounting officer of Fisher Scientific from 2005 to 2007.

She returned to public accounting as an audit partner at Deloitte & Touche from 2007 to 2014. Her assignments included Deloitte’s National Office Accounting Standards and Communications Group between 2007 and 2010.

In May 2014, Kramer became senior vice president and chief accounting officer of Hertz Global Holdings. She remained there until November 2018, when she joined Biogen as vice president and chief accounting officer. Biogen promoted her to senior vice president in December 2020.

Kramer became Biogen’s chief financial officer in March 2025 and joined its executive committee. She also chairs the board and audit committee of Armata Pharmaceuticals. Her earlier governance work includes the Massachusetts State Board of Accountancy, Probus Insurance Company Europe and the Center for Women & Enterprise.

Education

Kramer holds a B.S. in business administration, with an accounting specialization, from Salem State University. She is a licensed CPA in Massachusetts.